Drug: sorafenib Quarter: 2016Q3
Total Records: 167 Number of Pages: 9
| DRUGNAME | PT | EventCount |
|---|---|---|
| SORAFENIB (RAF KINASE INHIBITOR) | Nausea | 2 |
| SORAFENIB (RAF KINASE INHIBITOR) | Papillary thyroid cancer | 2 |
| SORAFENIB (RAF KINASE INHIBITOR) | Polyneuropathy | 2 |
| SORAFENIB (RAF KINASE INHIBITOR) | Thyroid cancer | 2 |
| SORAFENIB (RAF KINASE INHIBITOR) | Tumour necrosis | 2 |
| SORAFENIB | Abdominal pain | 1 |
| SORAFENIB | Activated partial thromboplastin time prolonged | 1 |
| SORAFENIB | Acute coronary syndrome | 1 |
| SORAFENIB | Acute hepatic failure | 1 |
| SORAFENIB | Acute kidney injury | 1 |
| SORAFENIB | Acute myeloid leukaemia | 1 |
| SORAFENIB | Adverse event | 1 |
| SORAFENIB | Arrhythmia | 1 |
| SORAFENIB | Atrioventricular block second degree | 1 |
| sorafenib | Bile duct obstruction | 1 |
| SORAFENIB | Bladder pain | 1 |
| SORAFENIB | Bladder spasm | 1 |
| sorafenib | Blood creatinine abnormal | 1 |
| SORAFENIB | Blood fibrinogen decreased | 1 |
| SORAFENIB | Blood pressure increased | 1 |
Total Records: 167 Number of Pages: 9